Purpose of review This article overviews advances in the genetics of puberty based on studies in the general population, describes evidence for sex-specific genetic effects on pubertal timing, and briefly reviews possible mechanisms mediating sexually dimorphic genetic effects.
INTRODUCTION
The onset of puberty is sexually dimorphic, occurring earlier in girls than in boys and exhibiting partly sex-specific impact on health. Recent large studies show strong evidence that pubertal timing is linked to a diverse range of adult health outcomes, some of which are shared while others are specific to either men or women [1 && ]. Investigation of the genetic underpinnings of pubertal timing within the general population may improve our understanding of male versus female differences in onset and associations with health outcomes. Significant discoveries have been made in recent years by incorporating ever-larger sample sizes, samples with diverse ethnic backgrounds, and traits which also allow the inclusion of males. In particular, studies in both sexes allow investigation not only of the common genetic underpinnings, but also of the differences. In this review, we provide a brief update of the key developments in our understanding of the genetics of normal pubertal timing, explore some evidence for sex-specific genetic effects in pubertal traits, and speculate on potential mechanisms that may mediate these effects.
Genetic studies of age at menarche: larger sample sizes and diverse ethnicities ]. Expanding the variants studied to include potentially functional low-frequency variants (with a minor allele frequency of 1-5%) and common variants on the X chromosome found an additional five and seven associated loci, respectively, but these variants only explained 0.5% more of the variance [4 && ]. The small amount of explained variance suggests that other types of genetic variation, such as copy number changes and gene-gene and epigenetically mediated gene-environment interactions [5 & ], should be investigated to help explain the missing heritability. It is also possible that variation in pubertal timing may be the result of hundreds or thousands of genetic variants with very small effect sizes.
Until recently, little overlap was seen between genes harboring rare, functionally damaging variants and genes near common variants known to influence puberty. However, with the publication of 106 AAM loci, a significant enrichment for signals in/near genes causing rare Mendelian puberty disorders was observed. Examples include makorin ring finger protein 3 (MKRN3), underlying central precocious puberty (CPP), and genes associated with hypogonadism, such as leptin receptor-leptin receptor overlapping transcript (LEPR-LEPTROT) and tachykinin receptor 3 (TACR3), encoding the neurokinin B receptor. In addition, a variant 10 kb away from gonadotropin-releasing hormone 1 (GNRH1) was suggestively associated with AAM [2 && ]. Other recent studies have examined puberty in non-European populations, notably in AfricanAmerican (AA) and Asian women (Table 1) . These studies mainly seek to replicate European loci, although not necessarily at the same SNPs. Candidate studies in AA women have had some success [6, 7] ; in one study, 25 of the 42 loci known at the time contained variants that were significantly associated in AA women. However, de novo GWAS in these samples failed to generate statistically significant novel loci, partly because of small sample sizes. Furthermore, the linkage disequilibrium structure differs between populations, with Europeans having longer stretches of linkage disequilibrium than African populations [8] , so widely used SNPchips aimed at tagging common European haplotypes may miss important variation in other ethnicities. In other populations, including Koreans [9] , Asians, Hispanics, and Native Hawaiians [10] , and Filipinos [11] , effect sizes for variants at the leading European loci (at lin-28 homolog B (LIN28B) and 9q31/transmembrane protein 38B (TMEM38B)) do appear robust across populations, although effect sizes vary by ethnicity (Table 1) . Taken together, these studies show that some known loci are important for pubertal onset regardless of ethnicity, and that larger sample sets are needed.
Epigenetics: imprinting and parent-of-origin effects
The role of epigenetics is a recent key advance in our understanding of the mechanisms regulating pubertal onset [5 & ]. In the large-scale GWAS of AAM, six loci fell in imprinted genomic regions and four of these had parent-of-origin effects, that is, only the paternal or maternal allele was associated with AAM [2 && ]. Of these, a paternally-inherited variant at MKRN3, an imprinted gene in the Prader-Willi syndrome critical region (chr 15q11-q13), was associated at a similar magnitude as variants at LIN28B (>0.1 years/allele). Concurrently, a wholeexome sequencing study of 40 individuals from 15 families with CPP found four heterozygous mutations in MKRN3 [12] . All individuals with CPP inherited the mutation from their fathers; individuals who inherited mutations from their mothers had normal puberty. Further studies revealed additional MKRN3 mutations in Brazilian [13] , Greek [14] , German [15] , Ashkenazi-Sephardic Jewish [16] , and Korean CPP cases [17] .
It is unknown whether MKRN3 or another gene, melanoma antigen family L2 (MAGEL2), is responsible for the GWAS signal [2 && ], as truncating mutations in MAGEL2 affecting paternal alleles have been reported in Prader-Willi cases with hypogonadism or delayed puberty [18] . In mice, however, levels of MKRN3 decreased in the arcuate nucleus of the
KEY POINTS
Significant discoveries into the genetic background of pubertal timing have been made in recent years by incorporating ever-larger sample sizes, samples with diverse ethnic backgrounds, and traits that also enable the study of puberty in males.
Studies in both sexes show that many genetic effects are similar between boys and girls, but differences also exist that may be important for understanding sexual dimorphism in pubertal timing and the associations between the timing of puberty and adult health.
Many mechanisms, including hormone-independent ones, may be responsible for sex-specific effects. 
NA
Until 2013, only European-descent populations were assessed for age at menarche in GWAS studies. The leading locus in these studies at LIN28B has since been assessed in various ethnicities. In this table, the effect at the LIN28B locus is summarized for various ethnicities, including the effect size and P value for the most recent European GWAS for reference [2
&&
]. These studies show that while variants at LIN28B are the most robust in Europeans, heterogeneity exists in other populations. For example, a GWAS in Korean women [6] did not report variants at this locus as significantly associated, and many other ethnicities show varied effects. GWAS, genome-wide association studies.
hypothalamus immediately before puberty [12] , and circulating MKRN3 also declines preceding pubertal onset in girls [19 & ]. Collectively, these data indicate that MKRN3 is part of the inhibitory brake that restrains puberty. It is interesting in this regard that when prepubertal rodent models were treated with chemicals modifying genomic epigenetic marks, each of three approaches showed results that were consistent with a mechanism in which epigenetically mediated suppression is lifted at the onset of puberty & ], and genes in the Jmj domain-containing lysinespecific demethylase family were highly enriched for association with AAM (enrichment P ¼ 0.006) in the most recent GWAS [2 && ]. Many genes in this family encode proteins that epigenetically modify specific methylation marks. In female mice, DNA methylation of Polycomb group silencing complex genes leads to the enrichment of activating H3 lysine modifications, triggering pubertal onset [20] . AAM has been inversely associated with global DNA methylation [21] , providing further evidence that an epigenetic switch plays an important role in the onset of puberty [22, 23] .
Sex differences and genetic effects on puberty
Several recent GWAS of pubertal traits investigated the genetic overlap in the regulation of pubertal phenotypes between boys and girls. These studies mainly focused on the commonalities between the sexes. However, differences also exist, and may prove important (Fig. 1) . For example, in a GWAS of the timing of the pubertal growth spurt, several variants were associated in only one sex in genderspecific analyses [24] , including rs960273 guanine nucleotide binding protein alpha 12 (GNA12) in males [P for sexual heterogeneity (P sex-het ) ¼ 5.2 Â 10 À4 ] and rs7628864 vestigial-like family member 3 (VGLL3) in females (P sex-het ¼ 6.8 Â 10 À6 ). Of these, rs7628864 was also associated with pubertal timing, whereas rs960273 showed sex-specific associations with total postnatal linear growth but not pubertal timing. Additionally, another study found an association between an AAM-associated locus, rs480014 Cdk5 and Abl enzyme substrate 1 (CABLES1), and taller childhood height in boys (P sex-het ¼ 0.04) but not girls, as well as other race and sex-specific associations with weight and BMI changes in adolescence [29] .
Two additional studies explored the overlap between menarche-associated variants and male genital and female breast development assessed by Tanner puberty scales [2 && ,26]. These studies concluded that much of the genetic architecture underlying pubertal timing is shared between the sexes, as the majority of alleles have concordant effect directions in males and females. However, further investigation of AAM-associated loci in male and female Tanner data revealed that not all menarche-associated loci behave the same way ( FIGURE 1. Puberty-associated loci with sex-specific effects. Genome-wide association studies have resulted in over 100 genome-wide significant loci for the pubertal traits of age at menarche, the timing of the pubertal growth spurt, and Tanner puberty staging. Body mass is a related trait that shares a genetic component with puberty. For age at menarche, 106 autosomal loci [2 && ], two X-chromosome loci, and five low-frequency loci [4 && ] are currently identified. There are five known loci, which are significantly associated with the pubertal growth spurt and pubertal timing [24] , and an additional two significant loci for Tanner staging [26] . Gene names are shown for loci at which sexspecific effects have been seen. For example, variants near LIN28B have been associated with age at menarche [2 && ,3], the timing of the pubertal growth spurt and postnatal growth [24, 25] , and Tanner stage [26] , with stronger associations seen in girls. Additionally, these LIN28B variants were also associated with body mass traits in adult women but not adult men [27, 28] . Other pubertal loci at which sex-specific effects have been seen include GNA12 and VGLL3 (24), CABLES1 [29] , and myocardin-like 2 (MKL2), mitochondrial carrier 2 (MTCH2), melanocortin 4 receptor (MC4R), Fanconi anemia, complementation group L (FANCL), and TMEM18 [26] . and rs2153127 at LIN28B and rs10453225 at TMEM38B; some loci show a strong association in one sex only, such as rs17233066 at spermidine/spermine N1-acetyltransferase family member 2 (SAT2B); and others have opposite effects, like rs1324913 at kruppel-like factor 12 (KLF12). It should be noted that the Tanner dataset was quite small, which could have resulted in imprecise estimates and random effects. Further in-depth studies of loci with sexspecific associations are necessary to understand sexual dimorphism in pubertal timing.
Sex-specific effects at LIN28B have been investigated in humans and mouse models. In humans, LIN28B variants have sex-specific associations with postnatal growth [25] , and are associated with adiposity traits in adult women, but not men [27, 28] . LIN28A and LIN28B participate in a negative feedback loop with the let-7 family of microRNAs. In mouse models of this pathway, Lin28b loss of function and reciprocal let-7 gain of function mice both displayed sex-specific effects on pubertal timing and growth (Corre, et al., in preparation) . Such data suggest that the LIN28-let-7 system is likely to have complex, partly sex-specific influences on growth and pubertal timing and that further study of this pathway in humans is warranted. A total of 123 menarche-associated variants were extracted from GWAS data on Tanner male genital stage and Tanner female breast stage (25) . The effect sizes are shown for the menarche-delaying alleles. In the Tanner data, beta values are derived directly from the Tanner scale, where 1 is prepubertal and 5 is adult phenotype. Thus, a negative beta value corresponds to later-than-average pubertal timing, since it reflects a lower Tanner score. Only four variants had significant P values for a difference between the sexes (P sex-dif ) at a Bonferoni-corrected significance threshold of 0.0004 (corrected for assessing 123 menarche-associated variants). A. Variants with a stronger effect in one sex versus the other. In some cases the variant appears to be associated with Tanner stage in both sexes but to a stronger degree in one sex versus the other, and in other cases the effect size is close to zero for one sex but higher in the other. B. Variants showing potentially opposite directions of effect. It should be noted that the dataset was relatively small (N males ¼ 3769; N females ¼ 6147), meaning that random effects may exist. BCL11A, B cell lymphoma 11 A; CA10, carbonic anhydrase X; CENPW, centromere protein W; CRTC1, Creb-regulated transcription coactivator 1; DET1, deetiolated homolog 1; EEFSEC, eukaryotic elongation factor, selenocysteine-tRNA-specific; FTO, fat mass and obesity associated; GPRC5B, G protein-coupled receptor C5B; GTF2I, general transcription factor IIi; GWAS, genome-wide association studies; KDM4A, lysine (K)-specific demethylase 4 A; KLF12, kruppel-like factor 12; LIN28B, Lin-28 homolog B; MKL2, myocardin-like 2; PEX2, peroxisomal biogenesis factor 2; SAT2B, spermidine/spermine N1-acetyltransferase family member 2; SIM1, single-minded family transcription factor 1; TMEM38B, transmembrane protein 38B. ]. b Position shown for genome build 37. c Menarche-delaying allele. d P value for sex difference is defined as the combined P value of both sexes assuming different effect sizes between them (two degrees of freedom). Adapted from http://www.well.ox.ac.uk/gwama/tutorial.shtml and [31] . e P value for sex heterogeneity is defined as the amount of heterogeneity in allelic effects between the sexes (one degree of freedom). Adapted from http:// www.well.ox.ac.uk/gwama/tutorial.shtml and [31] . FIGURE 2. Schematic representation of several mechanisms of sex-specific gene expression. The most fundamental difference between male and female cells is the sex chromosome complement; males possess an X and a Y chromosome, whereas females have two X chromosomes. Some examples of how male and female cells may experience differential gene expression include (a) sex-specific transcription factors, such as the male-specific SRY gene on the Y chromosome; (b) gene dosage because of incomplete X-inactivation in females, resulting in higher transcript levels in females for some genes; and (c) sexdifferentiated epigenetic marks, which may cause differential regulatory element usage, expression of different isoforms in each sex, or even differential gene expression entirely. In (d) a real example of a genetic variant Â sex Â epigenome interaction is schematically represented. In [35, 36] , genome-wide association studies-associated genetic variants at 7q12-q21 were associated with childhood-onset asthma in boys only, via sex-specific DNA methylation in response to smoking exposure. In the figure, variants A and B represent two DNA sequence variants in the associated region. Only boys with variant A have active gene expression in the presence of sex-specific DNA methylation. SRY, sex determining region Y.
Explaining sex differences
Sex-specific genetic effects are common in model organisms [30, 31] , and recent GWAS show that common genetic variation can influence traits or diseases in a sex-specific manner in humans (see [32 && ] for a recent review). Puberty is a dimorphic trait that displays sex-specific genetic effects. The mechanisms underlying sex-specificity remain largely speculative. Although sex hormones (testosterone and estrogen) are the primary drivers of differential gene expression, resulting in different trait manifestations and disease risks [33] , these hormones do not explain all sex differences. For example, in blastocysts, which are pregonadal and lack influence from sex hormones, almost a third of detected gene transcripts showed sexually dimorphic gene expression [34] , pointing toward an alternative mechanism prior to gonadal steroid synthesis.
The most fundamental difference between male and female cells is the sex chromosome complement (Fig. 2) . The X and Y chromosomes are structurally heteromorphic [37 & ] but share a pseudoautosomal region containing 29 genes [38] ; the human X and Y chromosomes have about 1400 [39] and 27 [40] unique genes, respectively. In humans, Turner (45-XO) and Kleinfelter (47-XXY) syndromes illustrate the implications of having the correct complement of sex chromosomes [41] . In mice, the Four Core Genotypes model has been used to test the contribution of the sex chromosomes versus the gonads [42] . In this model, a normal XX female is mated with a XY -sex determining region Y (Sry) male (with the Sry region translocated from the Y chromosome to an autosome), creating offspring with four potential genotypes: XX females, XY -females with normal autosomes and no Sry, XXSry males, and XY -Sry males with Sry on an autosome. In studies utilizing this model, X versus Y sex chromosome effects have been seen for many traits regardless of the hormonal milieu, including adiposity [43] , metabolism [44] , HDL cholesterol [45] , food intake [46, 47] , hypothalamic neuronal development [48] , brain structure and function [49] , and juvenile behavior [50] .
One way the sex chromosomes influence autosomal gene expression is through sex-linked genes acting as transcription factors, such as SRY [51, 52] (Fig. 2a) . Additionally, the sex chromosomes can reportedly affect epigenetic regulation of gene expression on the autosomes [53] . In 'Drosophila', the large heterochromatic Y chromosome directly impacts autosomal gene expression through effects on the epigenetic status of other chromosomes [54] [55] [56] 57 & ]. The heterochromatic inactive X may also bias autosomal expression [52, 53] .
Gene dosage is another contributor to sexspecific gene expression. Most genes on the second female X chromosome are randomly switched off, but around 15% escape X-inactivation and are expressed at twice the level found in males [58] . Mammalian embryos may have sex-specific gene expression before random X-inactivation [33] , which may have later-life effects on gene expression. In addition, 6-10% of autosomal genes are monoallelically expressed [59 & ], and in these cases, parentof-origin effects such as at MKRN3 can occur where a variant is expressed when it comes from one parent and not the other.
Epigenetic marks can be sex-specific and have lasting impact on sex-differentiated gene expression. For example, an X-linked gene was found that had significantly lower expression in males and was reduced further by in-utero maternal stress [60] . This gene had long-term effects on metabolic and neurodevelopmental programming [61] . Several studies showed long-lasting sex-specific epigenetic changes with transcriptional implications for nearby genes in the adult brain and liver, some of which are hormone-dependent [62 & ,63]. However, a small but significant increase in global autosomal methylation is associated with being male [64] , apparently not driven by sex hormones [65] . Epigenetic mechanisms are likely to play a large role in how certain genetic polymorphisms regulate gene expression differently in males and females. In lymphoblast cell lines grown without sex hormones, 12-15% of autosomal expression quantitative trait loci (eQTLs), genomic variants associated with variation in mRNA expression levels, were expressed in a sex-specific manner [66] because of differential usage of regulatory elements or isoforms [67, 68] .
In GWAS, mechanisms underlying sex-specific genetic associations remain mostly unknown. In two cases, a sex-specific eQTL overlapped a previously reported disease SNP, one for eosinophilic esophagitis and one for Crohn's disease, two conditions more common in men [66] . In other studies, epigenetic mechanisms, such as sex-specific DNA methylation in response to environmental cues, may be sequencedependent and have been highlighted [63, 64] .
CONCLUSION
Genetic investigation of pubertal timing is an active field of research with implications for understanding the biological basis for how pubertal maturation is triggered. In future research, more emphasis should be placed on sex-specific effects, as these may provide keys to understanding sexual dimorphism in pubertal onset and perhaps the associations between timing and later life health outcomes, some of which are also sex-specific.
